We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genomic Duplication Responsible for Rare Skin Disease

By LabMedica International staff writers
Posted on 15 May 2017
Through data analysis, ancestry mapping, genomic comparison, and international collaboration, researchers have identified the genetic mutation that causes the rare skin disease keratolytic winter erythema (KWE), or “Oudtshoorn skin,” in South African and Norwegian families.

Researchers at University of the Witwatersrand led the study in collaboration with peers in Europe, the USA, and Canada. More...
KWE causes a redness of the palms and soles with consecutive cycles of peeling of large sections of thick skin, often exacerbated during winter months. Oudtshoorn is a town in the Western Cape province of South Africa where the disorder was present in large families.

Afrikaners, the Afrikaans-language speakers descended from predominantly Dutch, German, and French settlers in South Africa, have a high risk for several genetic disorders (e.g. familial hypercholesterolaemia, porphyria, and the lesser known KWE) because of founder mutations brought by small groups who settled in the Cape of Good Hope and whose descendants are now spread throughout South Africa.

In 1977 KWE was found to occur with a dominant mode of inheritance (so, on average, if a parent has the condition about half the children inherit it in every generation). This early research has enabled dermatologists to make a definitive diagnosis and helped researchers better understand similar skin disorders.

In 1997, student Michelle Starfield guided by Michèle Ramsay, professor at Witz, and a group in Germany mapped the KWE trait to a region on the short arm of chromosome 8. The researchers showed that it was likely that the South African families all had the same mutation but that the German family had a different mutation. Later research focused on characterizing this region of the genome and examining good candidate genes. The KWE mutation remained elusive.

Subsequently, Wits student Thandiswa Ngcungcu, supervised by Prof. Ramsay, investigated KWE with large-scale DNA sequencing during an internship in Novartis, Basel. The mutation was not detected by conventional data analysis so copy-number variants (duplications or deletions) were investigated. Ngcungcu and colleagues discovered a duplication mutation in a genomic region between genes that was present in all South African KWE-affected individuals studied.

During this time Dr Torunn Fiskerstrand, University of Bergen, Norway, independently discovered a genomic duplication as the cause KWE in Norwegians. Ramsay and Fiskerstrand collaborated. The different DNA duplications in the South African and Norwegian families overlapped at a critical enhancer region, providing strong evidence that this was the KWE-causing mutation.

The scientists researched how this duplicated enhancer caused KWE and discovered that the mutation causes a nearby gene, CTSB, to produce more protein than normal and that this abnormal expression was the likely cause of the skin peeling disorder.

The study, by Ngcungcu T et al, was published in the May 2017 issue of the American Journal of Human Genetics.


New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
Pipette
Accumax Smart Series
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.